United States · Series D startup
Funding summaryUpdated 26 Oct 2026
$109Mraised across 7 rounds since 2007, from 7 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $22M sold, first sale Apr 2013
No investor was named in the report.
Reported by sec.govSEC filing: $8.6M sold, first sale Apr 2013
No investor was named in the report.
Reported by sec.govSEC filing: $14M sold, first sale Dec 2011
From a historical funding recordSEC filing: $14M sold, first sale Dec 2011
No investor was named in the report.
Reported by sec.govSEC filing: $3.0M sold, first sale Jul 2011
Reported by fiercebiotech.comSEC filing: $19M sold, first sale Jun 2009
Reported by presidiopharma.com
From the SEC filings it signed: 6 on the team.
On the board, as filediH. Daniel PerezOmar HaffarRobert WilliamsonScott Lessing
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
New Leaf Venture Partners
Panorama CapitalBaker Brothers Investments
Bay City CapitalVentures WestNexus Medical PartnersMissing a round, or an investor who was in one? Tell us.
Presidio Pharmaceuticals's investors include New Leaf Venture Partners, Panorama Capital, Baker Brothers Investments, Bay City Capital and Ventures West, and 1 more on record.
Presidio Pharmaceuticals has raised $109M across 7 rounds since 2007.
Presidio Pharmaceuticals's most recent round was a Series D of $22M in Jun 2014.
Presidio Pharmaceuticals's largest round on record is $27M (Venture), in Jul 2009.
Presidio Pharmaceuticals's first round on record, in Aug 2007, was backed by Bay City Capital, Panorama Capital and Ventures West and 2 others.
Presidio Pharmaceuticals's latest named round is a Series D, in Jun 2014.
Presidio Pharmaceuticals is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
